Page last updated: 2024-10-16

butyric acid and Liver Neoplasms

butyric acid has been researched along with Liver Neoplasms in 40 studies

Butyric Acid: A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.
butyrate : A short-chain fatty acid anion that is the conjugate base of butyric acid, obtained by deprotonation of the carboxy group.
butyric acid : A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group.

Liver Neoplasms: Tumors or cancer of the LIVER.

Research Excerpts

ExcerptRelevanceReference
"This is first study to unravel the association of butyrate producing bacteria with HCC patients and the significance of bacterial metabolite butyrate as anti-tumour in sorafenib resistant hepatocellular carcinoma."8.31Bacterial metabolite butyrate in modulating sorafenib-targeted microRNAs to curtail its resistance in hepatocellular carcinoma. ( Chakraborti, A; Dhiman, RK; Kanthaje, S; Kaur, R; Kumar, M, 2023)
" Recently, berberine (BBR) has been characterized as a modulator of PPARs; however, the matter of whether PPARs are involved in the inhibitory effect of BBR on hepatocellular carcinoma (HCC) is not well understood."8.31Berberine activates PPARδ and promotes gut microbiota-derived butyric acid to suppress hepatocellular carcinoma. ( Shaw, PC; Shou, JW, 2023)
" Thus, the objective of this study was to kinetically evaluate the antiangiogenic activity of tributyrin (TB), a butyric acid prodrug, in the promotion stage of hepatocarcinogenesis."7.91Antiangiogenic effects of the chemopreventive agent tributyrin, a butyric acid prodrug, during the promotion phase of hepatocarcinogenesis. ( Andrade, FO; Farsky, SHP; Fernandes, LHG; Furtado, KS; Hebeda, CB; Heidor, R; Horst, MA; Miranda, MLP; Moreno, FS; Sandri, S; Yamamoto, RC, 2019)
" In this study, we evaluated the combination of 1'-acetoxychavicol acetate (ACA), obtained from Alpinia galangal, and sodium butyrate, a major short chain fatty acid, on the growth of HepG2 human hepatocellular carcinoma cells and found that treatment had a synergistic inhibitory effect."7.80The synergistic effect of 1'-acetoxychavicol acetate and sodium butyrate on the death of human hepatocellular carcinoma cells. ( Azuma, H; Kato, R; Kojima-Yuasa, A; Matsui-Yuasa, I, 2014)
"This is first study to unravel the association of butyrate producing bacteria with HCC patients and the significance of bacterial metabolite butyrate as anti-tumour in sorafenib resistant hepatocellular carcinoma."4.31Bacterial metabolite butyrate in modulating sorafenib-targeted microRNAs to curtail its resistance in hepatocellular carcinoma. ( Chakraborti, A; Dhiman, RK; Kanthaje, S; Kaur, R; Kumar, M, 2023)
" Recently, berberine (BBR) has been characterized as a modulator of PPARs; however, the matter of whether PPARs are involved in the inhibitory effect of BBR on hepatocellular carcinoma (HCC) is not well understood."4.31Berberine activates PPARδ and promotes gut microbiota-derived butyric acid to suppress hepatocellular carcinoma. ( Shaw, PC; Shou, JW, 2023)
"Butyric acid (BA) has been reported to induce anticancer effects on hepatocellular carcinoma (HCC) cells both in vitro and in vivo."3.91Chitosan-coated liposomes loaded with butyric acid demonstrate anticancer and anti-inflammatory activity in human hepatoma HepG2 cells. ( Armenia, E; Barbarisi, A; Barbarisi, M; Caraglia, M; Giudice, A; Masarone, M; Persico, M; Quagliariello, V, 2019)
" Thus, the objective of this study was to kinetically evaluate the antiangiogenic activity of tributyrin (TB), a butyric acid prodrug, in the promotion stage of hepatocarcinogenesis."3.91Antiangiogenic effects of the chemopreventive agent tributyrin, a butyric acid prodrug, during the promotion phase of hepatocarcinogenesis. ( Andrade, FO; Farsky, SHP; Fernandes, LHG; Furtado, KS; Hebeda, CB; Heidor, R; Horst, MA; Miranda, MLP; Moreno, FS; Sandri, S; Yamamoto, RC, 2019)
" In this study, we evaluated the combination of 1'-acetoxychavicol acetate (ACA), obtained from Alpinia galangal, and sodium butyrate, a major short chain fatty acid, on the growth of HepG2 human hepatocellular carcinoma cells and found that treatment had a synergistic inhibitory effect."3.80The synergistic effect of 1'-acetoxychavicol acetate and sodium butyrate on the death of human hepatocellular carcinoma cells. ( Azuma, H; Kato, R; Kojima-Yuasa, A; Matsui-Yuasa, I, 2014)
"The purpose is to evaluate the CD44-mediated cellular targeting of HA-But, a hyaluronic acid esterified with butyric acid (But) residues, to hepatocellular carcinoma cell lines in vitro and to hepatic tumor metastases in vivo."3.72Inhibition of hepatocellular carcinomas in vitro and hepatic metastases in vivo in mice by the histone deacetylase inhibitor HA-But. ( Bello, M; Cantoni, S; Coradini, D; Mazzi, U; Pellizzaro, C; Perbellini, A; Rossin, R; Sava, G; Scarlata, I; Speranza, A; Turrin, C; Zorzet, S, 2004)
"Using in vivo and in vitro models of liver cancer, we demonstrate that an increase in the level of p53 protein in nuclei, a decrease in the level of cytoplasmic p53, and, consequently, an increase in the ratio of nuclear/cytoplasmic p53 in rat preneoplastic livers and in rat and human HCC cell lines caused by tributyrin or sodium butyrate treatments was associated with a marked increase in the level of nuclear chromosome region maintenance 1 (CRM1) protein."1.43Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein. ( Beland, FA; de Conti, A; Fernandes, LH; Furtado, KS; Heidor, R; Horst, MA; Moreno, FS; Ortega, JF; Pogribna, M; Pogribny, IP; Shpyleva, S; Tavares, PE; Tryndyak, V, 2016)
"Primary liver cancer has one of the highest mortality rates of all cancers, and the main current treatments have a poor prognosis."1.40Potential usefulness of baculovirus-mediated sodium-iodide symporter reporter gene as non-invasively gene therapy monitoring in liver cancer cells: an in vitro evaluation. ( Li, B; Liu, S; Pan, Y; Wu, H; Yin, H; Zhang, Y; Zhou, X, 2014)
"Treatment of HuH-7 human hepatocellular carcinoma (HCC) cells with 1-10 mM sodium butyrate (SB) resulted in growth inhibition in a dose-dependent manner."1.30Suppression of growth of hepatocellular carcinoma by sodium butyrate in vitro and in vivo. ( Fujimoto, J; Furuyama, J; Hashimoto-Tamaoki, T; Okamoto, E; Tamaoki, T; Yamamoto, H, 1998)
"Primary liver cancer is a significant health problem; treatment options are limited and prognosis is poor."1.30Effects of 5-azacytidine and butyrate on differentiation and apoptosis of hepatic cancer cell lines. ( Evers, BM; Li, J; Wang, X; Wang, XM, 1998)
"However the use of the human hepatoma cell line HepG2 as a model system for the regulation of CETP on mRNA level is facilitated by a quantitative reverse-transcribed polymerase chain reaction."1.29The expression of human plasma cholesteryl-ester-transfer protein in HepG2 cells is induced by sodium butyrate. Quantification of low mRNA levels by polymerase chain reaction. ( Budzinski, RM; Mark, M; Sperker, B, 1993)

Research

Studies (40)

TimeframeStudies, this research(%)All Research%
pre-19902 (5.00)18.7374
1990's22 (55.00)18.2507
2000's2 (5.00)29.6817
2010's9 (22.50)24.3611
2020's5 (12.50)2.80

Authors

AuthorsStudies
Yu, Q1
Dai, W1
Ji, J1
Wu, L1
Feng, J1
Li, J2
Zheng, Y1
Li, Y1
Cheng, Z1
Zhang, J1
Wu, J1
Xu, X1
Guo, C1
Kumar, M1
Kaur, R1
Kanthaje, S1
Dhiman, RK1
Chakraborti, A1
Shou, JW1
Shaw, PC1
Nouso, K1
Shiota, S1
Fujita, R1
Wakuta, A1
Kariyama, K1
Hiraoka, A1
Atsukawa, M1
Tani, J1
Tada, T1
Nakamura, S1
Tajiri, K1
Kaibori, M1
Hirooka, M1
Itobayashi, E1
Kakizaki, S1
Naganuma, A1
Ishikawa, T1
Hatanaka, T1
Fukunishi, S1
Tsuji, K1
Kawata, K1
Takaguchi, K1
Tsutsui, A1
Ogawa, C1
Ochi, H1
Yata, Y1
Kuroda, H1
Iijima, H1
Matono, T1
Shimada, N1
Yasuda, S1
Toyoda, H1
Kumada, T1
Ma, X1
Zhou, Z1
Zhang, X1
Fan, M1
Hong, Y1
Feng, Y1
Dong, Q1
Diao, H1
Wang, G1
Quagliariello, V1
Masarone, M1
Armenia, E1
Giudice, A1
Barbarisi, M1
Caraglia, M1
Barbarisi, A1
Persico, M1
Andrade, FO1
Furtado, KS2
Heidor, R2
Sandri, S1
Hebeda, CB1
Miranda, MLP1
Fernandes, LHG1
Yamamoto, RC1
Horst, MA2
Farsky, SHP1
Moreno, FS2
Hernández-Oliveras, A1
Izquierdo-Torres, E1
Meneses-Morales, I1
Rodríguez, G1
Zarain-Herzberg, Á1
Santiago-García, J1
Wang, HG1
Huang, XD1
Shen, P1
Li, LR1
Xue, HT1
Ji, GZ1
Pan, Y1
Wu, H1
Liu, S1
Zhou, X1
Yin, H1
Li, B1
Zhang, Y1
Kato, R1
Matsui-Yuasa, I1
Azuma, H1
Kojima-Yuasa, A1
Ortega, JF1
de Conti, A1
Tryndyak, V1
Fernandes, LH1
Tavares, PE1
Pogribna, M1
Shpyleva, S1
Beland, FA1
Pogribny, IP1
Kotantaki, P1
Mosialos, G1
Pant, K1
Yadav, AK1
Gupta, P1
Islam, R1
Saraya, A1
Venugopal, SK1
Coradini, D2
Zorzet, S1
Rossin, R1
Scarlata, I1
Pellizzaro, C1
Turrin, C1
Bello, M1
Cantoni, S1
Speranza, A2
Sava, G1
Mazzi, U1
Perbellini, A1
Morizane, T5
Watanabe, T4
Kagawa, T4
Tsunematsu, R1
Tada, S4
Miyaguchi, S2
Saito, H5
Tsuchiya, M3
Tsutsumi, T1
Ido, A1
Nakao, K1
Hamasaki, K1
Kato, Y1
Ohtsuru, A1
Nakata, K1
Tamaoki, T2
Nagataki, S1
Ebinuma, H2
Tsunematsu, S3
Kumagai, N2
Inagaki, Y1
Tsuchimoto, K1
Bode, BP1
Souba, WW1
Wadee, AA1
Paterson, A1
Coplan, KA1
Reddy, SG1
Sperker, B1
Mark, M1
Budzinski, RM1
Velázquez, OC1
Jabbar, A1
DeMatteo, RP1
Rombeau, JL1
Atsukawa, K1
Masuda, T1
Ishii, H1
Niki, S1
Haruyama, K1
Kokuno, S1
Itoi, T1
Mizoue, T1
Takei, K1
Mizumura, Y1
Sanada, J1
Mizuguchi, Y1
Ogihara, S1
Takeda, K1
Onoda, K1
Miwa, K1
Shinohara, Y1
Magami, Y1
Horibe, T1
Kakutani, H1
Niido, T1
Seki, T1
Hisa, T1
Saitou, T1
Yamamoto, H1
Fujimoto, J1
Okamoto, E1
Furuyama, J1
Hashimoto-Tamaoki, T1
Wang, XM1
Wang, X1
Evers, BM1
Hung, WC1
Chuang, LY1
Watkins, SM1
Carter, LC1
Mak, J1
Tsau, J1
Yamamoto, S1
German, JB1
Guevara, FM1
Kaptein, A1
Roodenburg, L1
Princen, HM1
Tokiwa, T1
Endo, A1
Sato, J1
Cook, JR1
Chiu, JF1
Tsukamoto, A1
Kaneko, Y1
Kurokawa, K1
Donadel, G2
Garzelli, C1
Frank, R1
Gabrielli, F2
Li, SY1
Bartalena, L1
Bogazzi, F1
Martino, E1
Pinchera, A1
Raymondjean, M1
Tichonicky, L1
Kruh, J1
Nakagawa, T1
Nakao, Y1
Matsui, T1
Koizumi, T1
Matsuda, S1
Maeda, S1
Fujita, T1

Reviews

1 review available for butyric acid and Liver Neoplasms

ArticleYear
Histone deacetylase inhibitors for treatment of hepatocellular carcinoma.
    Acta pharmacologica Sinica, 2005, Volume: 26, Issue:9

    Topics: Animals; Butyric Acid; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Enzyme Inhib

2005

Other Studies

39 other studies available for butyric acid and Liver Neoplasms

ArticleYear
Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c-myc/hexokinase 2 pathway.
    Journal of cellular and molecular medicine, 2022, Volume: 26, Issue:10

    Topics: Animals; Butyric Acid; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Proliferation; G

2022
Bacterial metabolite butyrate in modulating sorafenib-targeted microRNAs to curtail its resistance in hepatocellular carcinoma.
    Journal of cancer research and clinical oncology, 2023, Volume: 149, Issue:9

    Topics: Antineoplastic Agents; Bacteria; Butyric Acid; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Pro

2023
Berberine activates PPARδ and promotes gut microbiota-derived butyric acid to suppress hepatocellular carcinoma.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2023, Volume: 115

    Topics: Animals; bcl-2-Associated X Protein; Berberine; Butyric Acid; Carcinoma, Hepatocellular; Caspase 3;

2023
Effect of butyrate-producing enterobacteria on advanced hepatocellular carcinoma treatment with atezolizumab and bevacizumab.
    Cancer medicine, 2023, Volume: 12, Issue:17

    Topics: Bevacizumab; Butyric Acid; Carcinoma, Hepatocellular; Drug-Related Side Effects and Adverse Reaction

2023
Sodium butyrate modulates gut microbiota and immune response in colorectal cancer liver metastatic mice.
    Cell biology and toxicology, 2020, Volume: 36, Issue:5

    Topics: Animals; Butyric Acid; Cell Line, Tumor; Colorectal Neoplasms; Gastrointestinal Microbiome; Immunity

2020
Chitosan-coated liposomes loaded with butyric acid demonstrate anticancer and anti-inflammatory activity in human hepatoma HepG2 cells.
    Oncology reports, 2019, Volume: 41, Issue:3

    Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Butyric Acid; Carcinoma, Hepatocellular; Cell Survi

2019
Antiangiogenic effects of the chemopreventive agent tributyrin, a butyric acid prodrug, during the promotion phase of hepatocarcinogenesis.
    Carcinogenesis, 2019, 08-22, Volume: 40, Issue:8

    Topics: Actins; Angiogenesis Inhibitors; Animals; Apoptosis; Butyric Acid; Carcinogenesis; Carcinoma, Hepato

2019
Histone deacetylase inhibitors promote ATP2A3 gene expression in hepatocellular carcinoma cells: p300 as a transcriptional regulator.
    The international journal of biochemistry & cell biology, 2019, Volume: 113

    Topics: Animals; Butyric Acid; Carcinoma, Hepatocellular; E1A-Associated p300 Protein; Gene Expression; Hist

2019
Anticancer effects of sodium butyrate on hepatocellular carcinoma cells in vitro.
    International journal of molecular medicine, 2013, Volume: 31, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Butyric Acid; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tr

2013
Potential usefulness of baculovirus-mediated sodium-iodide symporter reporter gene as non-invasively gene therapy monitoring in liver cancer cells: an in vitro evaluation.
    Technology in cancer research & treatment, 2014, Volume: 13, Issue:2

    Topics: Baculoviridae; Butyric Acid; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Gene Expres

2014
The synergistic effect of 1'-acetoxychavicol acetate and sodium butyrate on the death of human hepatocellular carcinoma cells.
    Chemico-biological interactions, 2014, Apr-05, Volume: 212

    Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Benzyl Alcohols; Butyric Acid; Carc

2014
Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein.
    Oncotarget, 2016, Apr-26, Volume: 7, Issue:17

    Topics: Animals; Apoptosis; Butyric Acid; Carcinoma, Hepatocellular; Cell Compartmentation; Cell Line, Tumor

2016
The expression of tumor suppressor gene Cyld is upregulated by histone deacetylace inhibitors in human hepatocellular carcinoma cell lines.
    Cell biochemistry and function, 2016, Volume: 34, Issue:7

    Topics: Butyric Acid; Carcinoma, Hepatocellular; Cell Line, Tumor; Deubiquitinating Enzyme CYLD; Gene Expres

2016
Butyrate induces ROS-mediated apoptosis by modulating miR-22/SIRT-1 pathway in hepatic cancer cells.
    Redox biology, 2017, Volume: 12

    Topics: Antineoplastic Agents; Butyric Acid; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expre

2017
Inhibition of hepatocellular carcinomas in vitro and hepatic metastases in vivo in mice by the histone deacetylase inhibitor HA-But.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jul-15, Volume: 10, Issue:14

    Topics: Animals; Butyric Acid; Carcinoma, Hepatocellular; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Surv

2004
Antibody binding to liver cells and cell differentiation state.
    Advances in experimental medicine and biology, 1995, Volume: 371B

    Topics: Butyrates; Butyric Acid; Carcinoma, Hepatocellular; Cell Differentiation; Gene Expression; Humans; I

1995
Reciprocal regulation of alpha-fetoprotein and albumin gene expression by butyrate in human hepatoma cells.
    Gastroenterology, 1994, Volume: 107, Issue:2

    Topics: Albumins; alpha-Fetoproteins; Blotting, Northern; Butyrates; Butyric Acid; Carcinoma, Hepatocellular

1994
Changes of antigen expression on human hepatoma cell lines caused by sodium butyrate, a differentiation inducer.
    Journal of gastroenterology, 1994, Volume: 29, Issue:6

    Topics: Antibodies, Monoclonal; Antigens, Neoplasm; beta 2-Microglobulin; Butyrates; Butyric Acid; Carcinoma

1994
Modulation of cellular proliferation alters glutamine transport and metabolism in human hepatoma cells.
    Annals of surgery, 1994, Volume: 220, Issue:4

    Topics: Amino Acid Transport Systems; Amino Acids; Animals; Biological Transport; Butyrates; Butyric Acid; C

1994
HLA expression in hepatocellular carcinoma cell lines.
    Clinical and experimental immunology, 1994, Volume: 97, Issue:2

    Topics: Butyrates; Butyric Acid; Carcinoma, Hepatocellular; Clofazimine; Enzyme-Linked Immunosorbent Assay;

1994
The expression of human plasma cholesteryl-ester-transfer protein in HepG2 cells is induced by sodium butyrate. Quantification of low mRNA levels by polymerase chain reaction.
    European journal of biochemistry, 1993, Dec-15, Volume: 218, Issue:3

    Topics: Base Sequence; Blotting, Northern; Butyrates; Butyric Acid; Carcinoma, Hepatocellular; Carrier Prote

1993
Butyrate inhibits seeding and growth of colorectal metastases to the liver in mice.
    Surgery, 1996, Volume: 120, Issue:2

    Topics: Animals; Butyrates; Butyric Acid; Cell Division; Colorectal Neoplasms; Liver Neoplasms; Mevalonic Ac

1996
Reduction of LAK-sensitivity and changes in antigen expression on hepatoma cells by sodium butyrate.
    Cancer biochemistry biophysics, 1996, Volume: 15, Issue:3

    Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Antigens, Surface; Butyrates; Butyric Acid; Car

1996
[A case of hepatocellular carcinoma associated with autoimmune hepatitis and increased scintigraphy of liver accumulation].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1997, Volume: 94, Issue:3

    Topics: Autoimmune Diseases; Butyrates; Butyric Acid; Carcinoma, Hepatocellular; Female; Hepatitis; Humans;

1997
Suppression of growth of hepatocellular carcinoma by sodium butyrate in vitro and in vivo.
    International journal of cancer, 1998, Jun-10, Volume: 76, Issue:6

    Topics: Animals; Apoptosis; Butyrates; Butyric Acid; Carcinoma, Hepatocellular; Cell Division; Cyclin-Depend

1998
Effects of 5-azacytidine and butyrate on differentiation and apoptosis of hepatic cancer cell lines.
    Annals of surgery, 1998, Volume: 227, Issue:6

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Azacitidine; Blotting, Western; B

1998
Sodium butyrate enhances STAT 1 expression in PLC/PRF/5 hepatoma cells and augments their responsiveness to interferon-alpha.
    British journal of cancer, 1999, Volume: 80, Issue:5-6

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Butyric Acid; Carc

1999
Butyric acid and tributyrin induce apoptosis in human hepatic tumour cells.
    The Journal of dairy research, 1999, Volume: 66, Issue:4

    Topics: Acetylation; Apoptosis; Butyric Acid; Cell Nucleus; DNA Fragmentation; Histones; Humans; Liver Neopl

1999
Effect of dexamethasone, dimethylsulfoxide and sodium butyrate on a human hepatoma cell line PLC/PRF/5.
    Cancer biochemistry biophysics, 1992, Volume: 13, Issue:2

    Topics: alpha-Fetoproteins; Butyrates; Butyric Acid; Carcinoma, Hepatocellular; Cell Differentiation; Cell D

1992
Butyrate stimulates the secretion of apolipoprotein A-I and apolipoprotein B-100 in Hep G2 cells by different mechanisms.
    Clinical biochemistry, 1992, Volume: 25, Issue:5

    Topics: Apolipoprotein A-I; Apolipoprotein B-100; Apolipoproteins B; Butyrates; Butyric Acid; Carcinoma, Hep

1992
Butyrate decreases AFP and increases albumin in combination with laminin in a human hepatoma cell line.
    In vitro cellular & developmental biology : journal of the Tissue Culture Association, 1990, Volume: 26, Issue:3 Pt 1

    Topics: Albumins; alpha-Fetoproteins; Butyrates; Butyric Acid; Carcinoma, Hepatocellular; Culture Media; Hum

1990
Alpha-fetoprotein mRNA: variation of half-life in rat hepatoma cell lines and destabilization by sodium butyrate.
    Cell biology international reports, 1990, Volume: 14, Issue:7

    Topics: alpha-Fetoproteins; Animals; Butyrates; Butyric Acid; Dexamethasone; Glucocorticoids; Half-Life; Liv

1990
Differentiating effect of sodium butyrate on human hepatoma cell lines PLC/PRF/5, HCC-M and HCC-T.
    International journal of cancer, 1991, May-10, Volume: 48, Issue:2

    Topics: alpha-Fetoproteins; Blotting, Northern; Butyrates; Butyric Acid; Carcinoma, Hepatocellular; Cell Dif

1991
Novobiocin modulates cytokeratin assembly and differentiation of human hepatoma cells induced by butyrate and teleocidin.
    Cancer letters, 1991, Volume: 60, Issue:1

    Topics: Acetylation; Butyrates; Butyric Acid; Carcinogens; Carcinoma, Hepatocellular; Cell Transformation, N

1991
Identification of a novel nuclear protein synthesized in growth-arrested human hepatoblastoma HepG2 cells.
    European journal of biochemistry, 1991, Feb-14, Volume: 195, Issue:3

    Topics: Amino Acid Sequence; Autoradiography; Butyrates; Butyric Acid; Carcinoma, Hepatocellular; Cell Cycle

1991
[Expression of cellular oncogenes in human hepatocellular carcinoma cell line BEL 7402 and the effect of sodium butyrate on the expression of cellular oncogenes].
    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 1990, Volume: 12, Issue:3

    Topics: Butyrates; Butyric Acid; Carcinoma, Hepatocellular; Gene Expression Regulation, Neoplastic; Genes, r

1990
The differentiation-inducing agent sodium butyrate produces divergent effects on albumin and thyroxine-binding globulin synthesis by human hepatoblastoma-derived (Hep G2) cells.
    Journal of endocrinological investigation, 1990, Volume: 13, Issue:11

    Topics: Albumins; Butyrates; Butyric Acid; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Huma

1990
Effect of sodium butyrate on the complexity and the translation activity of hepatoma tissue-cultured cell RNAs.
    Biology of the cell, 1985, Volume: 54, Issue:1

    Topics: Animals; Butyrates; Butyric Acid; Carcinoma, Hepatocellular; Cells, Cultured; Electrophoresis, Polya

1985
Effects of sodium n-butyrate on alpha-fetoprotein and albumin secretion in the human hepatoma cell line PLC/PRF/5.
    British journal of cancer, 1985, Volume: 51, Issue:3

    Topics: Albumins; alpha-Fetoproteins; Butyrates; Butyric Acid; Carcinoma, Hepatocellular; Cell Line; Cyclohe

1985